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Abstract
Background: To investigate natural killer (NK) cell activity, circulating cytokine level and peripheral blood
mononuclear cell (PBMC) cytokine production status in critically ill patients.
Methods: Blood samples were collected <24 h after admission from 24 intensive care unit (ICU) patients and 24
age-, sex-, and body mass index (BMI)-matched healthy controls. Serum cytokine concentrations and cytokine
production by PBMCs and lipopolysaccharide (LPS)-stimulated PBMCs were measured.
Results: The ICU group showed lower NK cell activity than the controls under all conditions and an absence of
interferon (IFN)-γ. After adjusting for triglycerides, LDL- and HDL-cholesterol, and glucose, the ICU group exhibited
lower serum levels of albumin and interleukin (IL)-12 and higher leukocyte counts and hs-CRP and IL-6 levels than
the controls. Non-stimulated PBMCs from ICU patients secreted significantly greater amounts of IL-6 and IL-1β than
the controls; however, the production of IL-6, TNF-α and IL-1β in response to LPS stimulation was significantly
lower in the ICU group.
Conclusions: Significant reductions in NK cell activity and serum IL-12 level, an absence of serum IFN-γ, and decreased
cytokine production from LPS-stimulated PBMCs indicate the hyporesponsiveness of NK cells and an impaired early phase
inflammatory response in critically ill patients (ClinicalTrials.gov NCT02565589:). Retrospectively registered; October 1, 2015.
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Background
The host response to systemic infection and acute inflam-
matory states is characterized by fast and marked
alterations in innate and adaptive immunity [1]. Critically
ill patients with various conditions, including sepsis,
trauma, burns, hemorrhagic shock, and severe surgery,
show exacerbated production of proinflammatory media-
tors, a status that is called systemic inflammatory response
syndrome (SIRS) [2]. In response to this proinflammatory
state, there is a compensatory release of anti-inflammatory
substances, a status that is called compensatory anti-
inflammatory response syndrome (CARS) [2]. In general,
proinflammatory reactions are thought to be responsible
for collateral tissue damage in severe sepsis, whereas anti-
inflammatory responses are implicated in enhanced suscep-
tibility to secondary infections [3]. Accordingly, CARS
often leads to suppression of the immune system, which
makes patients vulnerable to nosocomial infections [4] and
leads to increased morbidity and mortality in the ICU [2].
Critical illnesses can deregulate every component of the
immune response [5–7]. In patients infected following
surgery, trauma, or burn, circulating monocytes exhibit
reduced production of IL-12 [8, 9]. Decreased monocyte
interleukin (IL)-12 production was significantly correlated
with adverse clinical outcomes [10]. Several circulating
cytokines and cytokine production by peripheral blood
mononuclear cells (PBMCs) play vital roles in critically ill
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patients [11–13]. The stimulated level of whole blood
cytokine production is theoretically a good indicator of
host immunity because it reflects actual cell function, such
as their ability to produce key cytokines involved in host
defense [14]. In a prospective cohort clinical study, the
number of CD14+ monocytes producing IL-12, tumor ne-
crosis factor (TNF)-α, and IL-6 after lipopolysaccharide
stimulation was 40% to 70% lower in trauma patients than
in healthy control subjects [8]. Critically ill pediatric pa-
tients with persistently low stimulated TNF-α production
are more likely to acquire life-threatening infections, and
treatment caused rapid improvement in stimulated TNF-α
production, which was associated with the prevention of
nosocomial infections [15, 16].
NK cells are crucial components of the innate immune
system, representing 10% of the cells in the total PBMC
population of circulating human lymphocytes, which is the
third largest lymphocyte population following B and T cells
[17]. NK cells contribute to the immune-inflammatory
reaction by producing many cytokines, particularly inter-
feron (IFN)-γ, a potent immune-stimulating cytokine [18].
NK cells have a protective role during infection but can
also be harmful during systemic inflammation and are
associated with lethality and experimental sepsis [19, 20].
In a comparison of ICU patients with severe sepsis or
septic shock or non-septic SIRS and healthy controls,
septic patients exhibited reduced IFN-γ production by NK
cells, whereas SIRS patients exhibited increased IFN-γ
production compared to that of sepsis patients or healthy
controls [21]. However, few studies have compared NK cell
activity in non-septic, critically ill patients with that in
healthy controls. Therefore, the aim of this study was to
investigate NK cell activities, circulating cytokine levels,
non-stimulated PBMC cytokine production, lipopolysac-
charide (LPS)-stimulated PBMC cytokine production, and
nutritional status in the early phase (< 24 h after ICU
admission) in critically ill patients in comparison with age-,
sex-, and body mass index (BMI)-matched healthy
controls.
Methods
Study design
Critically ill patients (ICU group, n = 24) were enrolled be-
tween April 2015 and July 2015 from Yonsei University
Severance Hospital after admission to the ICU. For valid-
ation of the experimental findings, age-, sex- and BMI-
matched healthy subjects were enrolled as controls from a
local health evaluation center during the same period (Clin-
icalTrials.gov: NCT02565589; http://www.clinicaltrials.gov).
Among the critically ill patients, 16 patients had pulmonary
disease, and 8 patients had trauma. Disease severity was
evaluated with the Acute Physiology and Chronic Health
Evaluation (APACHE) II score [22]. All of the patients were
treated according to appropriate guidelines [23, 24].
Written informed consent was provided from the healthy
participants and from a close family member for the ICU
group. Institutional Review Board at Yonsei University
Severance Hospital approved the study protocol, which was
conducted according to the Declaration of Helsinki.
Anthropometric parameters, biochemical assessments,
and cytokine and NK cell activity assays
Anthropometric parameters, serum lipid profiles, glucose,
nutritional status, liver and renal function tests, cytokine
levels in serum and PBMC supernatants, and NK cell activ-
ity were analyzed as previously described [25]. Detailed in-
formation about assessments of cytokine levels in serum and
PBMC supernatants, and NK cell activity were described in
supplementary information (See Additional File 1).
Statistical analysis
SPSS version 21.0 (IBM/SPSS Corp. Chicago, IL) was used
for statistical analysis. Comparisons between the control
and ICU groups were performed using the Chi-square test
for categorical variables and independent t-tests for con-
tinuous variables. Adjustment for confounding variables
was performed using an ANCOVA analysis. p-values under
0.05 were regarded as statistically significant, and p-values
for skewed variables were analyzed using log-transformed
data. The results are presented as the means ± standard
errors, and untransformed values are presented for
descriptive purposes. The relationships between variables
were examined using Pearson’s correlation coefficient and
visualized as a heat map.
Results
Clinical characteristics and serum cytokine levels
Compared with the age-, sex-, and BMI-matched healthy
controls, the ICU group exhibited a significant decrease in
triglycerides, total-, LDL- and HDL-cholesterol, albumin,
prealbumin, IL-12, and IFN-γ levels and a significant in-
crease in serum glucose, leukocyte count, and the serum
levels of hs-CRP, IL-6 and IL-1β (Table 1). The ICU group
exhibited an absence of IFN-γ (below the detection limit),
in contrast to the control group. The ICU group displayed
lower serum levels of albumin (p < 0.001), prealbumin (p
= 0.010), and IL-12 (p = 0.012) and a higher leukocyte
count (p = 0.012), hs-CRP (p < 0.001), and IL-6 (p < 0.001)
levels than the control group after adjustment for triglyc-
erides, LDL- and HDL-cholesterol and glucose levels.
NK cell activity and PBMC cytokine production in
response to LPS in ICU patients
NK cell activities determined in all conditions (E:T = 10:1,
5:1, 2.5:1 and 1.25:1) were significantly lower in the ICU
group than the control group (Table 2). Cytokine levels
measured in cultured PBMC supernatants following LPS
stimulation (0, 5, 10 ng/mL) for the control and ICU
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groups are shown in Table 2. Non-stimulated PBMCs from
ICU patients secreted significantly greater amounts of IL-6
and IL-1β into the culture media than those from healthy
controls. Both the control and patient groups showed in-
creases in the levels of TNF-α, IL-6 and IL-1β after LPS
stimulation. However, the production of IL-6 and TNF-α in
response to LPS stimulation (5 or 10 ng/mL) was lower in
the ICU group than the control group. Similarly, the pro-
duction of IL-1β in response to LPS stimulation (10 ng/
mL) was lower in the ICU group compared to the control
group (p = 0.001).
Correlations among age, BMI, leukocyte count, serum
levels of hs-CRP, albumin, and prealbumin, and PBMC
cytokine production
In the ICU group, there were significant positive correla-
tions among BMI, serum albumin, and serum prealbumin.
Serum prealbumin was weakly and negatively correlated
with age (r = −0.480, p = 0.021), moderately correlated with
hs-CRP (r = −0.530, p = 0.009), and positively correlated
with PBMC TNF-α production after LPS stimulation
(5 ng/mL) (r = 0.625, p = 0.002), which was also associated
with BMI (r = 0.567, p = 0.007) and serum albumin
(r = 0.633, p = 0.002). Non-stimulated PBMC IL-6 was posi-
tively associated with non-stimulated PBMC IL-1β
(r = 0.695, p < 0.001), which had a strong positive correl-
ation with LPS (5 ng/mL)-stimulated PBMC IL-1β
(r = 0.789, p < 0.001) and a low positive correlation with
TNF-α (r = 0.468, p = 0.033). There were positive correla-
tions among LPS (5 ng/mL)-stimulated PBMC IL-1β, LPS-
stimulated PBMC TNF-α, and LPS-stimulated IL-6 (Fig. 1).
In the control group, serum prealbumin was nega-
tively correlated with age (r = −0.611, p = 0.002). BMI
was positively and weakly correlated with the leukocyte
count (r = 0.482, p = 0.017) and negatively correlated
with non-stimulated PBMC TNF-α (r = −0.463,
p = 0.026), which was negatively associated with
leukocyte count (r = −0.571, p = 0.004) and positively
associated with serum albumin (r = 0.510, p = 0.013).
Non-stimulated PBMC TNF-α exhibited positive but
weak correlation with non-stimulated PBMC IL-1β
(r = 0.458, p = 0.028). Non-stimulated PBMC IL-6 was
strongly and positively correlated with non-stimulated
PBMC IL-1β (r = 0.779, p < 0.001), which showed
Table 1 Clinical characteristics in control and ICU patient groups
Control group (n = 24) ICU patient (n = 24) p0 p1
Age (year) 64.5 ± 2.05 64.6 ± 3.06 0.991
Male/Female n, (%) 18 (75.0) / 6 (25.0) 18 (75.0) / 6 (25.0) 1.000
BMI (kg/m2) 22.3 ± 0.40 22.4 ± 0.77 0.977
Height (cm) 163.7 ± 1.82 166.7 ± 1.41 0.201
Weight (kg) 64.0 ± 2.06 62.5 ± 2.69 0.669
Glucose (mg/dL)∮ 97.0 ± 4.95 211.4 ± 38.1 <0.001
Triglyceride (mg/dL)∮ 135.5 ± 9.41 104.8 ± 8.85 0.018
Total-cholesterol (mg/dL)∮ 216.3 ± 10.9 111.6 ± 7.16 <0.001
LDL-cholesterol (mg/dL)∮ 129.2 ± 10.1 61.4 ± 5.81 <0.001
HDL-cholesterol (mg/dL)∮ 59.8 ± 3.63 29.2 ± 2.85 <0.001
GOT (IU/L)∮ 28.5 ± 2.34 35.8 ± 6.02 0.708 0.155
GPT (IU/L)∮ 24.1 ± 1.91 22.2 ± 4.03 0.097 0.581
γ-GTP (U/L)∮ 34.8 ± 8.53 51.4 ± 15.9 0.967 0.520
BUN (mg/dL)∮ 15.1 ± 0.58 19.1 ± 2.54 0.811 0.294
Creatinine (mg/dL)∮ 0.82 ± 0.03 0.83 ± 0.07 0.556 0.567
Albumin (mg/dL)∮ 4.94 ± 0.11 2.77 ± 0.11 <0.001 <0.001
Prealbumin (mg/dL)∮ 25.6 ± 0.97 10.7 ± 0.97 <0.001 0.010
Leukocyte count (×103/μL)∮ 5.65 ± 0.25 10.8 ± 0.92 <0.001 0.012
hs-CRP (mg/L)∮ 1.01 ± 0.29 113.1 ± 15.1 <0.001 <0.001
IL-12 (pg/mL) 41.5 ± 7.78 2.49 ± 1.59 <0.001 0.012
IFN-γ (pg/mL) 14.8 ± 2.61 0.00 ± 0.00 <0.001 0.031
TNF-α (pg/mL)∮ 11.7 ± 2.27 6.49 ± 0.70 0.094 0.816
IL-6 (pg/mL)∮ 2.55 ± 0.28 56.4 ± 16.9 <0.001 <0.001
IL-1β (pg/mL∮∮ 0.56 ± 0.05 2.54 ± 0.15 0.001 0.091
Mean ± SE.∮tested by logarithmic transformation. p0: derived from independent t-test. p1: adjusted for glucose, triglyceride, LDL-cholesterol, and HDL-cholesterol
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positive but weak correlation with LPS (5 ng/mL)-stim-
ulated PBMC IL-1β (r = 0.484, p = 0.017) and IL-6 (r =
0.455, p = 0.025). There were strong positive correla-
tions among LPS (5 ng/mL)-stimulated PBMC IL-1β,
TNF-α, and IL-6 (Fig. 1).
Discussion
This study showed that NK cell activities were signifi-
cantly decreased under all conditions (E:T = 10:1, 5:1,
2.5:1, and 1.25:1) in the early phase in critically ill patients
compared with those in age-, sex-, and BMI-matched
Fig. 1 Correlation matrix among clinical and inflammatory parameters in control and ICU patient groups. Correlations were obtained by deriving
Pearson’s correlation coefficient. Red denotes a positive correlation, and blue denotes a negative correlation
Table 2 Natural killer cell activities and cytokine production from PBMCs
Control group (n = 24) ICU patient (n = 24) p
NK cell activity
NK cell activity E:T = 10:1 (%)∮ 27.4 ± 2.37 16.4 ± 1.99 0.002
NK cell activity E:T = 5:1 (%)∮ 20.8 ± 1.85 13.1 ± 2.15 0.006
NK cell activity E:T = 2.5:1 (%)∮ 20.1 ± 2.20 13.0 ± 1.94 0.011
NK cell activity E:T = 1.25:1 (%)∮ 23.1 ± 2.24 15.1 ± 2.19 0.013
Non-stimulated PBMC
TNF-α (pg/mL)∮ 2.03 ± 0.31 5.26 ± 1.48 0.103
IL-6 (pg/mL)∮ 12.1 ± 3.57 19.9 ± 3.29 0.039
IL-1β (pg/mL)∮ 0.70 ± 0.24 2.58 ± 0.51 0.002
PBMC (LPS 5 ng/mL)
TNF-α (pg/mL)∮ 299.7 ± 42.5 173.0 ± 39.2 0.007
IL-6 (pg/mL)∮ 2045.3 ± 341.9 685.9 ± 238.8 0.025
IL-1β (pg/mL)∮ 22.5 ± 5.90 18.0 ± 6.79 0.304
PBMC (LPS 10 ng/mL)
TNF-α (pg/mL)∮ 322.3 ± 49.2 210.5 ± 57.7 0.015
IL-6 (pg/mL)∮ 2479.2 ± 369.2 498.9 ± 108.4 <0.001
IL-1β (pg/mL)∮ 24.7 ± 3.77 15.2 ± 4.92 0.001
Mean ± SE.∮tested by logarithmic transformation. p: derived from independent t-test
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healthy controls. This finding is in accordance with an-
other recent study suggesting that NK cells and mono-
cytes exhibit hyporesponsiveness during critical illness
[26]. NK cells have the capacity to induce apoptosis or cell
lysis in tumor cells, virus-infected cells, and intracellular
parasites [27]. NK cells play an immuno-modulatory role
by secreting several cytokines, including IFN-γ, which ac-
tivates many key pathways related to antiviral functions
[17]. IL-12 is involved in stimulation of IFN-γ production
from T cells and NK cells [28]. Thus, the large reduction
in NK cell activity and serum IL-12 levels as well as the
absence of serum IFN-γ observed in the ICU group in this
study indicate NK cell hyporesponsiveness during the
early phase in critically ill patients.
Increased IL-12 production may be associated with in-
creased cellular immunity in critically ill patients. For in-
stance, LPS-stimulated PBMCs from survivors with severe
sepsis produced more IL-12 and less IL-10 than those from
nonsurvivors [12]. Similarly, the LPS-stimulated PBMCs
from survivors with septic shock produced more TNF-α
than those from nonsurvivors [29]. In this study, serum
TNF-α and TNF-α production by non-stimulated PBMCs
were not significantly different between the control and
ICU groups, while TNF-α production in response to LPS
stimulation (5, 10 ng/mL) was significantly lower in the
ICU group than the healthy controls. Additionally, TNF-α
production in response to LPS stimulation (5 ng/mL) in
the ICU group was positively correlated with nutritional
status, including BMI and the serum concentrations of
albumin and prealbumin. However, this association was
not observed in the healthy controls. Patients showing
impaired TNF-α production in leukocytes upon ex vivo
LPS stimulation have been reported to exhibit an increased
risk of developing nosocomial infections [30]. Therefore,
the positive correlation between TNF-α production in
response to LPS stimulation and nutritional status and the
negative correlation between hs-CRP and prealbumin
observed in the ICU group in this study suggest the
importance of nutritional therapy in critically ill patients to
improve health outcomes, including cellular immunity
[31–34].
Serum hs-CRP levels have been reported to positively
correlate with serum IL-6, which is always increased in
acutely ill patients with severe sepsis [26, 35]. Similarly,
the ICU group in this study showed higher serum levels
of hs-CRP and IL-6 and leukocyte count than the con-
trol group. Furthermore, the production of IL-6 and
IL-1β by non-stimulated PBMCs was higher in the ICU
group, although the production of IL-6 and IL-1β in
response to LPS stimulation was lower in the ICU
group. There is an age-related decline in cytokine pro-
duction by monocytes, particularly for the proinflamma-
tory mediators IL-6, TNF-α, and IL-1β [36–40]. Indeed,
older patients are known to exhibit less effective
neutrophil activity [37] and decreased NK cell cytotox-
icity and macrophage function [39, 41]. However, the
lower cytokine production following LPS stimulation in
the ICU group could have resulted from critical illness,
including pneumonia and trauma, rather than age, sex,
or low body weight, as the healthy controls were age-,
sex-, and BMI-matched to the critically ill patients in
this study. In this study, there was a closer correlation
between IL-6, TNF-α, and IL-1β levels from LPS-
stimulated PBMCs from the healthy controls compared
with the ICU group.
The limitations of this study must be addressed. First,
the sample size of 24 critically ill patients warrants con-
firmation in larger trials. Second, the study was an obser-
vational study, in which elucidating the cause and effect
relationships of specific (immunological and inflamma-
tory) mechanisms was not possible. Finally, our results do
not directly demonstrate that NK cell hyporesponsiveness
in the ICU group was significantly correlated with
decreased IL-12 and IFN-γ. Despite these limitations, we
observed greater reductions in NK cell activities and
serum IL-12 levels and an absence of serum IFN-γ in the
early phase in critically ill patients than in age-, sex-, and
BMI-matched healthy controls. We also detected a de-
crease in serum albumin and prealbumin and an increase
in the leukocyte count, serum IL-6, and hs-CRP. Further-
more, in contrast to the increased production of IL-6 and
IL-1β from non-stimulated PBMCs, the decreased pro-
duction of IL-6, TNF-α, and IL-1β from LPS-stimulated
PBMCs in the ICU group suggest an impaired inflamma-
tory response in critically ill patients.
Conclusions
This study investigated NK cell activities, circulating
cytokine levels and PBMC cytokine production status in
critically ill patients. The ICU group showed lower NK cell
activities and serum levels of albumin and IL-12 and
higher leukocyte counts and hs-CRP and IL-6 levels than
the controls. Non-stimulated PBMCs from ICU patients
secreted significantly higher amounts of IL-6 and IL-1β
than those from controls, while production of IL-6 and
TNF-α in response to LPS stimulation (5 or 10 ng/mL)
was lower in the ICU group. Similarly, the production of
IL-1β in response to LPS stimulation (10 ng/mL) was also
significantly lower in the ICU group. Our findings suggest
that great reductions in NK cell activities and serum IL-12
levels, an absence of serum IFN-γ, and decreased cytokine
production from LPS-stimulated PBMCs could indicate
the hyporesponsiveness of NK cells and an impaired
inflammatory response in the early phase of critical illness.
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